Investing.com - Zomedica Pharma (NYSE: ZOM) reported third quarter EPS of $-0.0010, worse than the analyst estimate of $0.0000. Revenue for the quarter came in at $6.35M versus the consensus estimate of $8.29M.
Zomedica Pharma's stock price closed at $0.1800. It is down -6.7400% in the last 3 months and down -20.7800% in the last 12 months.
Zomedica Pharma saw positive EPS revisions and negative EPS revisions in the last 90 days. See Zomedica Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, Zomedica Pharma's Financial Health score is "great performance".
Check out Zomedica Pharma's recent earnings performance, and Zomedica Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar